Israel wants flu vax made at home

The Israeli health ministry isn't content with contracting to buy vaccines against H1N1 "swine" flu; instead, the government has started negotiating with domestic pharma companies to set up a plant to make the shots in-country. Report

Suggested Articles

Mylan and Pfizer's Upjohn have a name for their pending merger: Viatris. Heard that before? So has Mylan, which owns a subsidiary with the same name.

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.